Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Curcumin Versus Ibuprofen for Exercise-Induced Muscle Damage in Physically Active Women (CURACTIVE)

20 августа 2026 г. обновлено: Diego Fernández Lázaro, University of Valladolid

Comparative Efficacy of Oral Curcumin Supplementation Versus Ibuprofen on Exercise-Induced Muscle Damage, Inflammation, Oxidative Stress, and Sports Performance in Physically Active Women: A Randomized Double-Blind Placebo-Controlled Trial

xercise-induced muscle damage (EIMD) is a common consequence of unaccustomed or high-intensity exercise and is characterized by muscle soreness, impaired physical performance, inflammation, oxidative stress, and increased circulating biomarkers of muscle damage. Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are frequently used to alleviate these symptoms, although their repeated use may be associated with adverse effects. Curcumin, a natural polyphenol with antioxidant and anti-inflammatory properties, has emerged as a potential nutritional strategy to support post-exercise recovery.

This randomized, double-blind, placebo-controlled trial aims to compare the effects of oral curcumin supplementation and ibuprofen administration on exercise-induced muscle damage in physically active women. The study evaluates clinical outcomes, physical performance, biomarkers of muscle damage, inflammation, oxidative stress, and other health-related biomarkers to determine whether curcumin may represent a safe and effective nutritional alternative for promoting recovery after eccentric exercise.

Обзор исследования

Статус

Завершенный

Условия

Вмешательство/лечение

Подробное описание

Exercise-induced muscle damage (EIMD) following eccentric exercise is characterized by structural disruption of skeletal muscle fibers accompanied by transient inflammation, oxidative stress, delayed-onset muscle soreness, and impaired physical performance. Although these responses are considered part of the normal adaptive process, excessive muscle damage may delay recovery and impair subsequent training or competition.

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used by athletes to reduce post-exercise pain and inflammation. However, repeated NSAID use has been associated with gastrointestinal, renal, and cardiovascular adverse effects, highlighting the need for safe nutritional alternatives capable of supporting recovery without interfering with physiological adaptation.

Curcumin, the principal bioactive polyphenol derived from Curcuma longa, exhibits antioxidant, anti-inflammatory, and cytoprotective properties through modulation of multiple molecular pathways involved in redox homeostasis and inflammatory signaling. Experimental and clinical studies suggest that curcumin may attenuate exercise-induced muscle damage by reducing oxidative stress, inflammatory responses, and muscle soreness, although evidence remains inconsistent and direct comparisons with NSAIDs are scarce.

The objective of this randomized, double-blind, placebo-controlled trial is to compare the efficacy of oral curcumin supplementation with ibuprofen and placebo in physically active women following eccentric exercise. The study evaluates clinical recovery, physical performance, biomarkers of muscle damage, inflammatory and oxidative stress biomarkers, and additional health-related biomarkers in order to characterize the physiological effects of curcumin supplementation and determine its potential role as a nutritional strategy for exercise recovery.

Тип исследования

Интервенционный

Регистрация (Действительный)

36

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

  • Испания
      • Soria, Испания, 42004
        • University Campus of Soria

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

  • Взрослый

Принимает здоровых добровольцев

Да

Описание

Inclusion Criteria:

Healthy physically active women. Age within the predefined study range. Regular participation in physical activity for at least 6 months before enrollment.

Ability to perform the eccentric exercise protocol. Written informed consent provided before participation.

Exclusion Criteria:

Current musculoskeletal injury or pain affecting exercise performance. History of cardiovascular, metabolic, neurological, renal, hepatic, or inflammatory disease.

Pregnancy or breastfeeding. Current use of anti-inflammatory drugs, antioxidant supplements, or other nutritional supplements that could interfere with study outcomes.

Known allergy or intolerance to curcumin, turmeric, ibuprofen, or study ingredients.

Smoking or excessive alcohol consumption. Participation in another clinical trial during the study period. Any condition considered by the investigators to compromise participant safety or protocol compliance.

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Уход
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Тройной

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Curcumin
Participants received oral curcumin supplementation according to the study protocol before and following the eccentric exercise protocol. Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.
Диетическая добавка: Curcumin
Participants received oral curcumin supplementation according to the study protocol before and after the eccentric exercise protocol. Curcumin was administered at the predefined dose and duration specified in the protocol. The intervention aimed to evaluate its effects on exercise-induced muscle damage, inflammation, oxidative stress, antioxidant defense, physical performance, and recovery in physically active women.
Другие имена:
  • Куркума длинная
Активный компаратор: Ibuprofen
articipants received oral ibuprofen according to the study protocol before and following the eccentric exercise protocol. Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.
Лекарство: Ibuprofen
Participants received oral ibuprofen according to the study protocol before and after the eccentric exercise protocol. Ibuprofen was administered at the predefined dose and duration specified in the protocol and served as the active comparator for evaluating recovery following exercise-induced muscle damage.
Плацебо Компаратор: Placebo
Participants received placebo capsules identical in appearance to the active interventions according to the study protocol before and following the eccentric exercise protocol. Clinical recovery, physical performance, muscle damage, inflammatory, oxidative stress, antioxidant defense, and other health-related biomarkers were evaluated during the recovery period.
Другой: Placebo
Participants received placebo capsules identical in appearance, packaging, and administration schedule to the active interventions. The placebo contained inert ingredients and was administered according to the study protocol before and after the eccentric exercise protocol.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Exercise-induced muscle damage
Временное ограничение: Baseline and during the 72-hour recovery period following eccentric exercise.
Exercise-induced muscle damage assessed using clinical outcomes and biochemical biomarkers following eccentric exercise to compare the effects of oral curcumin supplementation, ibuprofen, and placebo in physically active women.
Baseline and during the 72-hour recovery period following eccentric exercise.

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Creatine kinase (CK)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in serum creatine kinase concentration as a biomarker of exercise-induced skeletal muscle damage following eccentric exercise.
Baseline and during the 48-hour recovery period following eccentric exercise.
Lactate dehydrogenase (LDH)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in serum lactate dehydrogenase concentration as an indicator of muscle membrane disruption and tissue damage.
Baseline and during the 48-hour recovery period following eccentric exercise.
Aspartate aminotransferase (AST)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in serum aspartate aminotransferase concentration as an indirect biomarker of exercise-induced muscle tissue damage.
Baseline and during the 48-hour recovery period following eccentric exercise.
Alanine aminotransferase (ALT)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in serum alanine aminotransferase concentration following eccentric exercise.
Baseline and during the 48-hour recovery period following eccentric exercise.
Alkaline phosphatase (ALP)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in serum alkaline phosphatase concentration following eccentric exercise.
Baseline and during the 48-hour recovery period following eccentric exercise.
Interleukin-6 (IL-6)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in circulating interleukin-6 concentration as a biomarker of the inflammatory response to exercise-induced muscle damage.
Baseline and during the 48-hour recovery period following eccentric exercise.
C-reactive protein (CRP)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in serum C-reactive protein concentration as a marker of systemic inflammation following eccentric exercise.
Baseline and during the 48-hour recovery period following eccentric exercise.
Malondialdehyde (MDA)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in plasma malondialdehyde concentration as a biomarker of lipid peroxidation and oxidative stress.
Baseline and during the 48-hour recovery period following eccentric exercise.
Superoxide dismutase (SOD)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in superoxide dismutase activity as an indicator of endogenous antioxidant defense.
Baseline and during the 48-hour recovery period following eccentric exercise.
Catalase (CAT)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in catalase activity as a marker of antioxidant defense following eccentric exercise.
Baseline and during the 48-hour recovery period following eccentric exercise.
Delayed-onset muscle soreness (DOMS)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in perceived muscle soreness assessed using a validated visual analogue scale following eccentric exercise.
Baseline and during the 48-hour recovery period following eccentric exercise.
Countermovement jump (CMJ)
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in countermovement jump performance as a measure of lower-limb neuromuscular function and exercise recovery.
Baseline and during the 48-hour recovery period following eccentric exercise.
Thigh circumference
Временное ограничение: Baseline and during the 48-hour recovery period following eccentric exercise.
Changes in thigh circumference as an indirect indicator of exercise-induced muscle swelling.
Baseline and during the 48-hour recovery period following eccentric exercise.

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

University of Valladolid

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

31 января 2026 г.

Первичное завершение (Действительный)

23 мая 2026 г.

Завершение исследования (Действительный)

1 августа 2026 г.

Даты регистрации исследования

Первый отправленный

20 августа 2026 г.

Впервые представлено, что соответствует критериям контроля качества

20 августа 2026 г.

Первый опубликованный (Действительный)

25 августа 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

25 августа 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

20 августа 2026 г.

Последняя проверка

1 августа 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Ключевые слова

Дополнительные соответствующие термины MeSH

Другие идентификационные номера исследования

  • DFL-CURC-2025-01

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

ДА

Описание плана IPD

ndividual participant data that underlie the results reported in publications arising from this study (after de-identification) will be made available upon reasonable request to the corresponding investigator. Data will be shared with researchers who provide a methodologically sound proposal and whose proposed use of the data has been approved by the study investigators and complies with applicable ethical and institutional regulations.

Сроки обмена IPD

Beginning 6 months after publication and ending 5 years after publication.

Критерии совместного доступа к IPD

Data will be available upon reasonable request to qualified researchers for scientifically sound research purposes following approval by the study investigators and execution of a data sharing agreement, when required.

Совместное использование IPD Поддерживающий тип информации

  • STUDY_PROTOCOL

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться